Application Nr Approved Date Route Status External Links
ANDA060593 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications & Usage Section Cycloserine Is Indicated In The Treatment Of Active Pulmonary And Extrapulmonary Tuberculosis (Including Renal Disease) When The Causative Organisms Are Susceptible To This Drug And When Treatment With The Primary Medications (Streptomycin, Isoniazid, Rifampin, And Ethambutol) Has Proved Inadequate. Like All Antituberculosis Drugs, Cycloserine Should Be Administered In Conjunction With Other Effective Chemotherapy And Not As The Sole Therapeutic Agent. Cycloserine May Be Effective In The Treatment Of Acute Urinary Tract Infections Caused By Susceptible Strains Of Gram–positive And Gram–negative Bacteria, Especially Enterobacter Spp. And Escherichia Coli. It Is Generally No More And Is Usually Less Effective Than Other Antimicrobial Agents In The Treatment Of Urinary Tract Infections Caused By Bacteria Other Than Mycobacteria. Use Of Cycloserine In These Infections Should Be Considered Only When More Conventional Therapy Has Failed And When The Organism Has Been Demonstrated To Be Susceptible To The Drug.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Cycloserine CYCLOSERINE ZINC34676245

Comments